Table 1.
Parameters | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 |
---|---|---|---|---|---|---|---|
* Quality control | |||||||
Swirling | Positive | Positive | Positive | Positive | Positive | Negative | Negative |
PC volume | 3 mL | 3 mL | 3 mL | 3 mL | 3 mL | 3 mL | 3 mL |
Leukocyte count (108/70 mL) |
0.51 ± 0.02 | 0.48 ± 0.02 | 0.42 ± 0.03 | 0.34 ± 0.03 | 0.25 ± 0.04 * | 0.18 ± 0.06 * | 0.12 ± 0.06 * |
Platelet count (1010) | 7.3 ± 0.10 | 6.9 ± 0.11 | 6.7 ± 0.15 | 6.4 ± 0.18 | 6.1 ± 0.21 | 5.8 ± 0.24 | 5.5 ± 0.30 |
pH | 7.2 ± 0.02 | 7.2 ± 0.03 | 7.2 ± 0.01 | 7.3 ± 0.01 | 7.3 ± 0.02 | 7.3 ± 0.01 | 7.4 ± 0.05 |
miRNAs expression ** | |||||||
miR-127 | 0.30 ± 0.12 | 0.41 ± 0.16 | 0.43 ± 0.19 | 0.32 ± 0.17 | 0.24 ± 0.23 | 0.29 ± 0.21 | 0.35 ± 0.25 |
miR-320a | 0.19 ± 0.11 | 0.27 ± 0.13 | 0.37 ± 0.13 * | 0.53 ± 0.18 * | 0.54 ± 0.19 * | 0.56 ± 0.22 * | 0.62 ± 0.22 * |
Membrane proteins’ expression + | |||||||
P2Y12 | 39.57 ± 2.14 | 39.48 ± 1.73 | 40.56 ± 1.97 | 41.64 ± 1.56 | 41.19 ± 1.28 | 42.87 ± 1.80 | 42.69 ± 1.32 |
CD62P | 11.45 ± 3.12 | 13.76 ± 4.61 | 18.96 ± 5.22 | 21.70 ± 6.22 * | 33.76 ± 6.25 * | 38.26 ± 7.11 * | 40.20 ± 7.17 * |
CD41 | 94.32 ± 4.20 | 89.81 ± 2.81 | 87.54 ± 2.52 | 85.73 ± 1.98 | 80.11 ± 2.53 * | 78.81 ± 3.22 * | 75.54 ± 2.60 * |
CD61 | 87.62 ± 3.43 | 83.51 ± 3.72 | 80.31 ± 3.53 | 78.13 ± 2.46 | 77.14 ± 3.25 * | 75.21 ± 3.27 * | 73.11 ± 4.10 * |
Values are expressed as means ± standard deviations. * Gravimetric measurement. ** Values referring to the relative quantification of miRNAs mir127 mir320a, for mir-191. + Percentage of platelets positive for CD62P and for GPIIb and -IIIa. For the P2Y12 receptor, the mean fluorescence intensity (MFI) was evaluated.